Geeshath Jayasekera1, Colin Church1, Martin Johnson1, Andrew Peacock1, and Aleksandra Radjenovic2
1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United Kingdom, 2Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
Synopsis
Pulmonary hypertension is a rare progressive
disorder characterised by elevated pulmonary artery pressure leading to right
ventricular failure and death. Native T1 mapping is a CMR technique for
myocardial tissue characterisation that does not require MRI contrast
administration1. We investigated whether native T1 values relate to invasive
pressure measurements and markers of RV dysfunction in patients with pulmonary
hypertension. Background
Pulmonary hypertension is a rare progressive
disorder characterised by elevated pulmonary artery pressure leading to right
ventricular (RV) failure and death. Cardiac MR (CMR) derived right and left
ventricular functional variables were shown to be prognostic in pulmonary
hypertension
1. We showed that late gadolinium enhancement (LGE) occurs at the
Right Ventricular insertion points in patients with pulmonary hypertension
2. It is suggested that a predilection for fibrosis to develop at
the inter-ventricular insertion regions is caused by mechanical stress due to
the bowing of the inter-ventricular septum into the Left ventricle (LV). Native
T1 mapping is a CMR technique for myocardial tissue characterisation that does
not require MRI contrast administration
3. We investigated whether native T1 values relate to invasive
pressure measurements and markers of RV dysfunction in patients with pulmonary
hypertension (PH). We hypothesized that native T1 mapping maybe used as an
alternative to LGE for characterisation of the RV insertion points in patients
with PH.
Methods
36 patients
suspected of pulmonary hypertension underwent cardiac MR and right heart
catheterisation (male = 19, mean age 62 ± 15.1). Ventricular volumes and
ejection fraction were determined by CMR while pulmonary artery pressure
measurements, cardiac output and pulmonary vascular resistance (PVR) were
obtained during right heart catheterisation.
T1 maps were acquired on a Siemens Avanto 1.5T scanner using a MOLLI
sequence
4 on a mid ventricular short axis plane with a
trigger delay to coincide with systole. Native T1 values were determined using
regions of interest (ROI) in the RV insertion points, Inter-ventricular septum
(IVS) and left ventricle (LV). ROI size and placement ensured avoidance of
partial volume effects.
Results
Six
of the 36 patients did not have pulmonary hypertension on right heart
catheterisation. The other 30 patients (male =18, mean pulmonary artery
pressure 47 ± 14 mmHg) consisted of 21 WHO Group 1 patients ( 8 Idiopathic
Pulmonary Arterial Hypertension, 4 Connective Tissue Disease PH, 3 porto-pulmonary
PH, 2 Congenital Heart Disease PH, 4 Pulmonary Veno-Occlusive Disease), 2
patients with PH secondary to left heart disease, 2 patients with PH associated
with hypoxaemia and 5 patients with chronic thromboembolic pulmonary
hypertension. Raised native T1 values at the RV insertion points were visually
identified in all but one patient (mPAP 26, PVR 3.4 Wood Units) with pulmonary
hypertension. In patients with pulmonary hypertension RV insertion point T1
values (1079±70) were significantly higher (p<0.001) compared to LV (984±43)
and the inter-ventricular septum (985±40). There was no significant difference
in T1 values between LV free wall and IVS. In PH patients Native T1 values of
the RV insertion points were significantly correlated to RV Ejection Fraction
(p = 0.004 Pearson R =-0.524), RV End Diastolic Volume Index (p = 0.001 Pearson
R = 0.579), RV End Systolic Volume Index (p < 0.001 Pearson R 0.660) but not
to CMR derived Left ventricular indices and Cardiac output or PVR at right
heart catheterisation.
Conclusions
The native
T1 values of the RV insertion points are increased in patients with pulmonary
hypertension and are associated with CMR markers of RV dysfunction. These may
suggest myocardial histological changes occurring at the right ventricular
insertion points. Native T1 imaging may become a potential biomarker in
patients with pulmonary hypertension and may be an alternative to late
gadolinium enhancement without the need for a contrast agent.
Acknowledgements
British
Heart Foundation, Siemens Medical for provision of the prototype T1-mapping
sequence References
1. Peacock
AJ, Vonk Noordegraaf A. Cardiac magnetic resonance imaging in pulmonary
arterial hypertension. Eur Respir Rev. 2013;22(130):526-34.
2. Blyth
KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, et al. Contrast
enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary
hypertension. Eur Heart J. 2005;26(19):1993-9.
3. Kellman
P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc
Magn Reson. 2014;16:2.
4. Messroghli
DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified
Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the
heart. Magn Reson Med. 2004;52(1):141-6.